Literature DB >> 22392063

Pharmacotherapy. Elevating HDL-cholesterol levels with dalcetrapib is safe.

Gregory B Lim.   

Abstract

Entities:  

Year:  2012        PMID： 22392063     DOI： 10.1038/nrcardio.2012.31

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial.

Authors:  Thomas F Lüscher; Stefano Taddei; Juan-Carlos Kaski; J Wouter Jukema; David Kallend; Thomas Münzel; John J P Kastelein; John E Deanfield
Journal:  Eur Heart J       Date:  2012-02-16       Impact factor: 29.983
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.